摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoate | 1365259-13-7

中文名称
——
中文别名
——
英文名称
methyl 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoate
英文别名
methyl 6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentyl-methylamino]hexanoate
methyl 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoate化学式
CAS
1365259-13-7
化学式
C18H33N3O3S
mdl
——
分子量
371.544
InChiKey
DJRZACSFPZYPBH-ZOBUZTSGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    549.2±45.0 °C(Predicted)
  • 密度:
    1.089±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    25
  • 可旋转键数:
    13
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    96
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoate 在 sodium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 以88 mg的产率得到6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoic acid
    参考文献:
    名称:
    BIOTINYLATED POLYSACCHARIDES HAVING AN ANTITHROMBOTIC ACTIVITY AND IMPROVED METABOLIC STABILITY
    摘要:
    该发明涉及具有抗血栓活性的新型多糖,其与生物素或生物素衍生物之一至少具有一个共价键,其中所述共价键对代谢裂解具有抵抗性,并且包括选自—O—、—N(R)—、—N(R)—CO—和—N(R′)—CO—N(R″)—的连接X,其中R是烷基基团,而R′和R″(可以相同也可以不同)分别为氢原子或烷基基团。
    公开号:
    US20130190268A1
  • 作为产物:
    描述:
    methyl 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)hexanoatedimethyl sulfide borane 作用下, 以 四氢呋喃 为溶剂, 反应 16.0h, 以55 mg的产率得到methyl 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoate
    参考文献:
    名称:
    BIOTINYLATED POLYSACCHARIDES HAVING AN ANTITHROMBOTIC ACTIVITY AND IMPROVED METABOLIC STABILITY
    摘要:
    该发明涉及具有抗血栓活性的新型多糖,其与生物素或生物素衍生物之一至少具有一个共价键,其中所述共价键对代谢裂解具有抵抗性,并且包括选自—O—、—N(R)—、—N(R)—CO—和—N(R′)—CO—N(R″)—的连接X,其中R是烷基基团,而R′和R″(可以相同也可以不同)分别为氢原子或烷基基团。
    公开号:
    US20130190268A1
点击查看最新优质反应信息

文献信息

  • BIOTINYLATED POLYSACCHARIDES HAVING AN ANTITHROMBOTIC ACTIVITY AND IMPROVED METABOLIC STABILITY
    申请人:SANOFI
    公开号:US20130190268A1
    公开(公告)日:2013-07-25
    The invention relates to novel polysaccharides with an antithrombotic activity, having at least one covalent bond with biotin or a biotin derivative, wherein said covalent bond is resistant to metabolic cleavage and comprises a linkage X selected from the group consisting of —O—, —N(R)—, —N(R)—CO— and —N(R′)—CO—N(R″)—, wherein R is an alkyl group and R′ and R″, which may be identical or different, are, independently of one another, a hydrogen atom or alkyl group.
    该发明涉及具有抗血栓活性的新型多糖,其与生物素或生物素衍生物之一至少具有一个共价键,其中所述共价键对代谢裂解具有抵抗性,并且包括选自—O—、—N(R)—、—N(R)—CO—和—N(R′)—CO—N(R″)—的连接X,其中R是烷基基团,而R′和R″(可以相同也可以不同)分别为氢原子或烷基基团。
查看更多

同类化合物

生物素-C5-叠氮 樟磺咪芬 四氢-4-(5-羟戊基)-(3AS,4S,6AR)-1H-噻吩并[3,4-D]咪唑-2(3H)-酮 咪噻吩 利地霉素 5-硫杂-1,2A-二氮杂环戊并[Cd]并环戊二烯 1,3-二苄基-2-氧代十氢噻吩并[1',2':1,2]噻吩并[3,4-d]咪唑-5-鎓溴化物 (3AS,4S,6AR)-1,3-二苄基-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-甲醛 (3aS,4S,6aR)-4-(5-(1-(2-hydroxybenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one (3aS,4S,6aR)-4-(5-(1-(3-methoxybenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one methyl (4E,Z)-6-({5-[(3aS,4S,6aR)-1,3-bis(4-methoxybenzyl)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}oxy)hex-4-enoate 1H-thieno<3,4-d>imidazol-2(3H)-one, tetrahydro-4-(5-chloropentyl)-, <3aS-(3aα,4β,6aα)>- (3aS,4Z,6aR)-5-{hexahydro-2-oxo-4H-thieno[3,4-d]imidazol-4-ylidene}pentanoic acid methyl ester (3aS,6aR)-1,3-dibenzyl-tetrahydro-1H-thieno[3,4-d]-imidazole-2(3H)-one-4-yl-pentanoic acid (3aS,4S,6aR)-4-(5-(1-(4-iodobenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 1-amino-17-N-(biotinylamido)-3,6,9,12,15-pentaoxaheptadecane (3aS,4S,6aR)-4-(4-isocyanatobutyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 2-[1-Hydroxy-5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentylidene]-5,5-dimethyl-cyclohexane-1,3-dione (3aS,4S,6aR)-4-(4-aminobut-1-yl)hexahydro-1H-thieno[3,4-d]imidazolidin-2-one hydrochloride Methyl-bisnorbiotinyl-keton 3,4-(1',3'-Dibenzyl-2'-oxoimidazolido)-2-hydroxy-thiophen 5-[({4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}carbamoyl)amino]pentanoic acid tert-butyl 5-[({4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}carbamoyl)amino]pentanoate 1-{5-[(2,5-dioxopyrrolidin-1-yl)oxy]-5-oxopentyl}-3-{4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}urea Trimetaphan camsylate (3aS,4S,6aR)-4-hexyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one 1-Benzyl-1,3a,4,6,7,8,8a,8b-octahydrothieno[1',2':1,2]thieno[3,4-d]imidazol-5-ium-2-olate--hydrogen chloride (1/1) (3aα,6aα)-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazole (3aα,6aβ)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (E)-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pent-2-enoic acid (3aS,4Z,6aR)-1,3-dibenzyl-4-(3-methoxypropylidene)-6,6a-dihydro-3aH-thieno[3,4-d]imidazol-2-one (3aS,6aR)-1-Isopropyl-5,5-dioxo-hexahydro-5λ6-thieno[3,4-d]imidazol-2-one (3AS-cis)-1,3-dibenzyltetrahydro-4-(3-methoxypropylidene)-1H-thieno(3,4-d)imidazol-2(3H)-one (3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 2-oxo-(3ar,3bξ,8ac)-decahydro-thieno[1',2':1,2]thieno[3,4-b]imidazolium; bromide biotin hydrazide (3aS,4S,6aR)-1,3-bis[(3-bromophenyl)methyl]-4-(5-hydroxypentyl)-3a,4,6,6a-tetrahydrothieno[3,4-d]imidazol-2-one 4-Pentyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-3-benzyl-4-pentyl-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-4-hept-6-ynyl-2-oxo-tetrahydro-thieno[3,4-d]imidazole-1,3-dicarboxylic acid di-tert-butyl ester (3aS,4S,6aR)-4-(6-hydroxyhexyl)-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-4-oct-7-ynyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoic acid 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentyl dimethyl phosphite Methyl-tetranorbiotinyl-keton (2aR,7aS,7bS)-Hexahydro-2H-1-thia-3,4a-diazacyclopent[cd]inden-4(3H)-one 8-(2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)octanoic acid 2'-thiobiotinol